The activity of TGF-beta 1 is regulated primarily extracellularly wher
e the secreted latent form must be modified to expose the active molec
ule. Here we show that thrombospondin-1 is responsible for a significa
nt proportion of the activation of TGF-beta 1 in vivo. Histological ab
normalities in young TGF-beta 1 null and thrombospondin-1 null mice we
re strikingly similar in nine organ systems. Lung and pancreas patholo
gies similar to those observed in TGF-beta 1 null animals could be ind
uced in wild-type pups by systemic treatment with a peptide that block
ed the activation of TGF-beta 1 by thrombospondin-1. Although these or
gans produced little active TGF-beta 1 in thrombospondin null mice, wh
en pups were treated with a peptide derived from thrombospondin-l that
could activate TGF-beta 1, active cytokine was detected in situ, and
the lung and pancreatic abnormalities reverted toward wild type.